Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lucobit AG is a German specialty chemicals company that develops, produces, and markets high-quality polymers and bitumen-based materials for technical applications. Headquartered in Wesseling, the company was established in 2000 as a spin-off from a joint venture between BASF and Shell. Its core product lines include Lucofin, a range of ethylene butyl acrylate (EBA) copolymers, and Lucobit, which are utilized in the construction, automotive, and packaging industries. In the healthcare sector, Lucobit provides medical-grade plastics specifically designed for the manufacturing of flexible films, medical bags, and tubing, ensuring high purity and performance for medical device applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LUCOBIT.